Thrombin induces a number of physiological responses in several types of cells. To determine the action of thrombin in the vein, the electrophysiological and mechanical effects of thrombin were studied in rat portal vein smooth muscle cells. Ca2' channel currents were recorded using the whole-cell patch-clamp technique. Thrombin had both inhibitory and stimulatory effects on the Ca2' channel current. The inhibitory effect was reversed on washout of thrombin, whereas the stimulatory effect was maintained after thrombin was removed. Thrombin (1 unit/ml) produced a reversible decrease of 27.3 ±3.3% (n = 12) in the current amplitude and a sustained increase of 71.2+12.9%o (n=20). The thrombin-induced inhibition of Ca2' channel current was blocked by the thrombin inhibitor hirudin and by the protease inhibitor leupeptin. The stimulatory effect of thrombin was inhibited by hirudin, by intracellular application of guanosine 5'-O-(.&thio)diphosphate, and by antiphosphatidylinositide antibodies but not by pertussis toxin. The thrombin-induced enhancement of the Ca2`channel current amplitude was not observed when the current was previously stimulated by phorbol 12,13-dibutyrate. This suggests that the inhibitory effect of thrombin was related to its proteolytic activity and that the stimulatory effect involved activation of a pertussis toxin-insensitive GTP-binding protein, phosphatidylinositide hydrolysis, and protein kinase C activation. Both thrombin effects occurred in the same concentration range (0.001-10 units/ml The aim of the present study was to characterize the electrophysiological effects of thrombin on vascular smooth muscle cells isolated from rat portal vein and to identify the mechanisms that potentially could underlie thrombin actions.
Thrombin induces a number of physiological responses in several types of cells. To determine the action of thrombin in the vein, the electrophysiological and mechanical effects of thrombin were studied in rat portal vein smooth muscle cells. Ca2' channel currents were recorded using the whole-cell patch-clamp technique. Thrombin had both inhibitory and stimulatory effects on the Ca2' channel current. The inhibitory effect was reversed on washout of thrombin, whereas the stimulatory effect was maintained after thrombin was removed. Thrombin (1 unit/ml) produced a reversible decrease of 27.3 ±3.3% (n = 12) in the current amplitude and a sustained increase of 71.2+12.9%o (n=20). The thrombin-induced inhibition of Ca2' channel current was blocked by the thrombin inhibitor hirudin and by the protease inhibitor leupeptin. The stimulatory effect of thrombin was inhibited by hirudin, by intracellular application of guanosine 5'-O-(.&thio)diphosphate, and by antiphosphatidylinositide antibodies but not by pertussis toxin. The thrombin-induced enhancement of the Ca2`channel current amplitude was not observed when the current was previously stimulated by phorbol 12,13-dibutyrate. This suggests that the inhibitory effect of thrombin was related to its proteolytic activity and that the stimulatory effect involved activation of a pertussis toxin-insensitive GTP-binding protein, phosphatidylinositide hydrolysis, and protein kinase C activation. Both thrombin effects occurred in the same concentration range (0.001-10 units/ml). The thrombin-induced contraction of portal vein strips was completely inhibited by isradipine, and thrombin did not produce an increase in cytosolic [Ca2"], measured by indo-1 fluorescence in cells clamped at -50 mV, sufficient to activate Ca2'-dependent chloride current. Thus, the effects 
Results

Effects of Thrombin on Mechanical Activity
Application of thrombin (1 unit/ml) on longitudinal strips of portal vein induced a slow increase in tension accompanied by an enhancement of the amplitude and frequency of spontaneous activity ( Figure 1A , tracing a). When thrombin was removed, the basal tension slowly returned to its initial level. The effects on spontaneous contractions were much more maintained. The amplitude of contractions went on increasing after thrombin was washed out. After more than 1 hour, the amplitude and the frequency of spontaneous contractions were still stimulated. The effect of thrombin was also studied on the muscular strip already stimulated by NA ( Figure 1A , tracing b). NA (3 ,uM) produced a large contraction consisting of a phasic component followed by a sustained phase, mainly dependent on calcium entry through voltage-dependent Ca 2+ channels, which were stimulated through a protein kinase C (PKC) pathway.2126 Thrombin (1 unit/ml) partially inhibited (approximately 25%) the maintained component of the NA-induced contraction. This effect was rapidly reversed when thrombin was removed. This observation suggests that, when the vein was already contracted by other agonists, the effect of thrombin was a partial relaxation.
In the presence of the Ca>2 channel blocker isradipine (0.1 ,uM), application of thrombin (1 unit/ml) did not produce any change in tension ( Figure 1B) 
Effects of Thrombin on Ca21 Channel Current
Effects of thrombin were studied on Ca 2+ channels by using 5 mM barium as the charge carrier. Experiments were started after perfusion of the cells with a bariumcontaining PSS for at least 30 minutes. The Ca21 channel currents were evoked by repetitive depolarizations from a holding potential of -60 mV at a frequency of 0.05 Hz. Under these conditions, within 20 minutes, the decrease of the Ca21 channel current due to the rundown phenomenon was weak (11.2±1.8%, n=13). The first thrombin application was done at least 4 minutes after establishment of the whole-cell configuration, and zero time on the figures had no specific meaning. Application of thrombin (1 unit/ml) produced an increase in the amplitude of the Ca21 channel current evoked by depolarization to 0 mV from a holding potential of -60 mV ( Figure 2A ). The current amplitude reached a stable value after 2-2.5 minutes of thrombin application. Surprisingly, the current amplitude started again to increase when thrombin was removed, and a new steady state was reached 1-2 minutes after thrombin washout; the maximal increase measured at this time was between 25% and 260% of the control current, depending on the cells, with a mean value of 71.2±12.9% (n =20). This prazosin. A second application of thrombin (1 unit/ml) on the stimulated current produced a decrease in the current amplitude ranging between 9% and 54% with a mean value of 27.3-+3.3% (n=12). The percentages of increase and decrease given here were calculated from cells in which both thrombin effects were observed at the first application. These two effects were abolished when thrombin (1 unit/ml) was applied in the presence of hirudin (2 units/ml, Figure 2B ), which is known to specifically antagonize the action of thrombin by binding to it. As shown in Figure 2A , the current amplitudes reached during both applications of thrombin were similar. Since the effect of the second application of thrombin was only a reversible inhibition of the stimulated current, it is possible that the effect observed during the first application was the result of an inhibition of the Ca2' channel current, which was reversed upon washout of thrombin, and a maintained increase in the Ca2' channel current amplitude, which persisted after thrombin was removed. Thus, the increase in the current amplitude occurring after the termination of the first thrombin application could correspond to the washout of the inhibitory effect. This hypothesis agreed with the maintained stimulation of spontaneous contractions and with the reversible inhibition of the NA-induced contraction produced by thrombin application on strips voltage pulse without any change in the voltage threshold, the potential for the maximal current, or the apparent reversal potential ( Figure 3A ). As shown in Figure 3B , the inhibition of the Ca22 channel current did not significantly alter the steady-state inactivation curve. The midpoint of the curve was -43.2±1.7 mV (n==4) in control conditions and -45.7±1.1 mV (n=4, p>0.3) in the presence of 1 unit/ml thrombin. Similarly, the stimulatory effect of thrombin (1 unit/ml) did not change the voltage threshold, the potential for the maximal current, or the apparent reversal potential of the current-voltage relation ( Figure 4A ). Figure 4B shows the mean peak conductance curves against volt- creases the Ca2+ channel current is not a simple leftward shift of the steady-state activation curve. The effects of thrombin on Ca'+ channels might be due to its enzymelike properties. In an attempt to check this hypothesis, experiments were done in the presence of the protease inhibitor leupeptin, known to prevent thrombin-catalyzed proteolysis without inhibiting thrombin binding.28 In the presence of 100 ,ug/ml leupeptin in the barium-containing PSS, thrombin (5 units/ ml) induced a sustained increase in the Ca 2 channel current amplitude, but contrary to that observed under control conditions, the thrombin-induced increase reached a steady state during thrombin application ( Figure SA) . The enhancement of the Ca21 channel current produced by thrombin in the presence of leupeptin corresponded to 103.3+7.2% (n=3) of the stimulation induced under control conditions in the same batch of cells, indicating that the thrombin-induced enhancement of Ca 2+ current was not affected by leupeptin. During the second thrombin application, the reversible inhibition of the current seen under control conditions was not observed. This result shows that the thrombin-induced inhibition of the Ca2+ channel current was blocked by leupeptin, suggesting that this effect was linked to the proteolytic activity of thrombin.
A GTP-binding protein (G protein) has been implicated in the thrombin signaling system in several types of cells.1229-32 To know whether a G protein is important in the portal vein myocyte response to thrombin, we included GDP-,3-S in the pipette solution. This stable analogue of GDP acts as a competitive inhibitor of G protein activation by GTP and thereby inhibits agonistinduced activation.33 Because GDP-,B-S was added to the pipette solution, it was not possible to compare the effects of thrombin in the presence and absence of GDP-,B-S on the same cell. Thus, the effect of GDP-,B-S was only studied in cell batches in which both inhibitory and stimulatory actions of thrombin on Ca 2 channel current were observed in more than 90% of the cells; the results were compared with those obtained under control conditions in the same cell batch. With 1 mM GDP-13-S in the pipette solution, application of 1 unit/ml thrombin failed to produce an increase in peak inward current elicited by depolarizing pulses to 0 mV from a holding potential of -60 mV but still induced a reversible inhibition ( Figure SB) Previous studies in portal vein smooth muscle cells have demonstrated that voltage-dependent Ca 2 channels were modulated through PKC activation.26 To determine whether thrombin acted via PKC activation, thrombin was applied in the presence of PDBu, a phorbol ester known to directly activate PKC. This experiment was performed in cell batches in which thrombin induced both inhibition and stimulation of the Ca 2 channel current in at least 90% of the cells tested under control conditions. As illustrated in Figure 6A , when the peak inward current elicited by depolarizing pulses to 0 mV from a holding potential of -60 mV was maximally stimulated by 0.1 ,uM PDBu (90.4+9.6%, n=28), a further application of thrombin (1 unit/ml) did not produce an additional increase in current amplitude but induced an inhibition that was maintained as long as thrombin was present. A second application of thrombin (1 unit (27. 5±2.8%, n=6) in the inward current amplitude, which returned to its initial value when thrombin was removed, whereas PDBu (0.1 ,uM) was still able to produce an increase in the Ca2+ channel current ( Figure 6B ). This decrease was similar to that obtained during the second application of thrombin in the same batch of cells under control conditions (28.0+4.4%, n=4, p>0.5). This effect is consistent with an involvement of phosphatidylinositides in the intracellular transduction mechanism responsible for the thrombininduced enhancement of the Ca2+ channel current. In addition, the involvement of a phosphorylation (maybe through PKC activation) was supported by the strong inhibition of the thrombin-induced enhancement of the Ca2+ channel current when the pipette solution did not contain ATP (Figure 7 ). Under these conditions, only an inhibition of the Ca2+ channel current (22 
Concentration Dependence of Thrombin Action on Ca2+ Channel Current
The inhibitory and stimulatory effects of increasing concentrations of thrombin were measured on Ca2+ channel current obtained at 0 mV from a holding potential of -60 mV. The inhibitory effect was measured from the second response to thrombin or from cells that showed only an inhibition of the Ca2' channel current in the presence of thrombin. A maximal inhibition (approximately 30% of control current) was obtained in the presence of thrombin concentrations greater than 0.1 unit/ml ( Figure 8A ). The thrombin concentration required to produce 50% of the maximal inhibition (IC50) was estimated to be 0.0061 unit/ml, because the mean value for -log IC50 and the standard error obtained from the fit of the data were 2.21±0.06.
To reduce variability, the stimulatory effect of thrombin was expressed as a fraction of the total increase in the Ca 2+ channel current induced by a sequential application of thrombin and 0.1 ,uM PDBu. The measurement of the effect of thrombin was made when the current reached a steady state after thrombin was removed. The maximal stimulation (approximately 80% of the PDBu effect) was obtained with 0.1-10 units/ml thrombin, and the concentration giving 50% of the maximal effect (EC5O) was 0.0053 unit/ml ( Figure 8B , -log EC50=2.27+0.11). These results indicate that the 38 The presence of only a few thrombin receptors on the portal vein membrane activating a few G proteins and then leading to the formation of relatively low concentrations of intracellular second messengers may explain these results.
However, thrombin (1 unit/ml) and NA (10 ,gM)26 stimulate the Ca21 channel current to nearly the same extent, and although the amplitude of the thrombininduced contraction was lower than that of the NAinduced contraction, the effect of thrombin on the spontaneous activity was more maintained than that of NA. Our results suggest that, like NA-induced stimulation,26 thrombin-induced stimulation of the Ca2' channel current involved DAG production. Thus, it is possible that thrombin caused DAG production by more than one mechanism, even if the action of the antiPtdlns Abs suggested that the phosphatidylinositides were the only substrates of DAG production, since anti-Ptdlns Abs were bound to phosphatidylinositol and also, with a lower affinity, to phosphatidylinositol monophosphate and phosphatidylinositol diphosphate but did not bind phosphatidylcholine and phosphatidylethanolamine.34 This hypothesis is supported by the ability of thrombin to produce in platelets sequential activation of a phosphatidylinositol diphosphate-specific phospholipase C, followed by activation of a phosphatidylinositol monophosphate-and phosphatidylinositol-specific phospholipase C.3940 In addition, it has been recently reported that the first phase of the multiphasic generation of DAG in thrombin-activated platelets was due to phospholipase C-mediated hydrolysis of phosphatidylinositol diphosphate, whereas the subsequent phases were not derived from phosphatidylinositol diphosphate. 41 In light of these studies, it should not be surprising to find a dissociation between responses depending on DAG and InsP3. If such mechanisms for DAG production were stimulated by thrombin in portal vein smooth muscle cells, thrombin could induce formation of as much DAG as NA but with different kinetics; this could explain the difference in the time course of the NA-and the thrombin-induced stimulation of Ca>2 channels.
The observations we report concerning the thrombin effects on electrophysiological and mechanical properties of venous smooth muscle are novel and provide the basis for both conclusions and speculation about thrombin physiological and physiopathological roles. Under normal conditions, when the integrity of the endothelium is maintained, it is unlikely that thrombin comes into direct contact with vascular smooth muscle cells. However, endothelium damage and/or the setting of a thrombus are likely to bring myocytes into direct contact with clotting factors. Under these circumstances, it is of interest to speculate that thrombin may act as a plasmaderived humoral mediator of electrophysiological events. Because of its dual effect on voltage-dependent Ca21 channels, the action of thrombin might be different: in resting myocytes, the effect of thrombin would be a contraction; on the contrary, in myocytes already contracted by other agonists (such as NA), the action of thrombin would be a partial relaxation.
